Search clinical trials for: EMR

Total 644 results

Merck KGaA, Darmstadt, Germany
Threshold Pharmaceuticals

Completed

A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer

Pancreatic Cancer | Solid Tumor

Japan
EMD Serono

Completed

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

Solid Tumor

United States
Theratechnologies

Terminated

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Diabetic Retinopathy | HIV

United States
Theratechnologies

Terminated

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

HIV

United States
Massachusetts General Hospital

Completed

Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial) (EDGE)

Constipation | Hirschsprung Disease

United States
Centre Hospitalier Universitaire de Nice

Completed

Recto Colonic Endoscopic Mucosal Resection and Polypectomy Under Clopidogrel (MEDOC)

Polyps

France
Chonnam National University Hospital

Withdrawn

Comparison of Small Colorectal Polyp Removal Using Cold EMR With Hot EMR

Colonic Polyps

Korea, Republic of
EMD Serono

Terminated

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

Advanced Solid Tumor

United States
EMD Serono

Completed

Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia

Parkinson's Disease | Dyskinesia

United States
Merck KGaA, Darmstadt, Germany

Completed

Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, Germany
Bayer

Completed

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b (ADHERENCE)

Multiple Sclerosis
Kliniken Ludwigsburg-Bietigheim gGmbH

Unknown

Endoscopic Resection of Non-ampullary Duodenal Adenomas: Endoscopic Mucosal Resection (EMR) vs. Endoscopic Full-thickness Resection With the 'Duodenal Full-thickness Resection Device' (dFTRD) (DUO-RESECT)

Duodenal Adenoma

Germany
Medipol University

Unknown

The Effect of Pilates Group Exercise Program

Sedentary Lifestyle

Turkey
Rima Obeid
Merck KGaA, Darmstadt, Germany; Syneed Medidata GmbH

Completed

The Vitamin B Status in Type 2 Diabetes (VITA) Study (VITA)

Diabetes Mellitus, Type 2 | Vitamin B 12 Deficiency | Vitamin B 6 Deficiency
EMD Serono

Completed

Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

Parkinson's Disease | Dyskinesia

United States
Istanbul University

Unknown

Preoperative Exercise Test and Postoperative Intensive Care Unit Need in Bariatric Surgery

Morbid Obesity | Weaning Failure

Turkey
EMD Serono
National Cancer Institute (NCI)

Completed

Tecemotide (L-BLP25) in Prostate Cancer

Prostate Cancer

United States
Boston Scientific Corporation

Completed

The Captivator EMR Registry

Barrett's Esophagus

United States, Canada, Belgium, United Kingdom, Netherlands, Germany
University of Sao Paulo General Hospital
Ministry of Health, Brazil

Unknown

Electronic Medical Records and Genomics

Heart Failure

Brazil
BioMarin Pharmaceutical

Terminated

Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria (SIGNAL)

Phenylketonuria

Italy, Switzerland
University Health Network, Toronto
Merck Frosst Canada Ltd.

Withdrawn

A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

Pancreatic Adenocarcinoma | Metastatic Disease | Advanced Disease
Children's Hospital Medical Center, Cincinnati

Terminated

Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease

Crohn Disease

United States
Indiana University
Department of Health and Human Services; Regenstrief Institute, Inc.

Completed

Aspiring to Awesome- Patient Preference Privacy Selections in EMR

Sexually Transmitted Diseases

United States
EMD Serono
Merck KGaA, Darmstadt, Germany

Completed

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

United States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
Merck KGaA, Darmstadt, Germany
Merck Ltd.

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea (ECOS KOR)

Growth Disorders

Korea, Republic of
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain (ECOS ESP)

Growth Disorders

Spain
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment (ECOS CHN)

Growth Disorders

China
Merck KGaA, Darmstadt, Germany
Merck S.A. Columbia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia (ECOS COL)

Growth Disorders

Colombia
Merck KGaA, Darmstadt, Germany
Merck A.B., Sweden

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden (ECOS SWE)

Growth Disorders

Sweden
Merck KGaA, Darmstadt, Germany
Merck spol.s.r.o., Czech Republic

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic (ECOS CZ)

Growth Disorders

Czechia
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia (ECOS AUS)

Growth Disorders

Australia
Merck KGaA, Darmstadt, Germany
Merck Gesellschaft mbH, Austria

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria (ECOS AUT)

Growth Disorders

Austria
Merck KGaA, Darmstadt, Germany
EMD Serono, a division of EMD Inc., Canada

Completed

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment (ECOS CAN)

Growth Disorders

Canada
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ LLC

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East (ECOS UAE)

Growth Disorders

Germany
Merck KGaA, Darmstadt, Germany
Merck Kft., Hungary

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary (ECOS HUN)

Growth Disorders

Hungary
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy (ECOS ITA)

Growth Disorders

Italy
Merck KGaA, Darmstadt, Germany
Merck spol. s r.o., Slovakia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia (ECOS SVK)

Growth Disorders

Slovakia
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France (ECOS FRA)

Growth Disorders

France
Merck KGaA, Darmstadt, Germany
Merck Quimica Argentina S.A.I.C

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina (ECOS ARG)

Growth Disorders

Argentina
Merck KGaA, Darmstadt, Germany
Merck S.A. de C.V., Mexico

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico (ECOS MEX)

Growth Disorders

Mexico
Merck KGaA, Darmstadt, Germany
Merck A.E., Greece

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece (ECOS GRE)

Growth Disorders

Greece
Threshold Pharmaceuticals

Terminated

Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer

Pancreatic Cancer

United States
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly (CHOLINE)

Multiple Sclerosis

France
Threshold Pharmaceuticals

Completed

Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma (MAESTRO)

Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

United States, Germany
Merck KGaA, Darmstadt, Germany

Completed

An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

Adult Growth Hormone Deficiency

United Kingdom, Germany, Australia, Sweden
Institut Paoli-Calmettes

Unknown

Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid Technique (HYBRID ESD)

Colorectal Adenoma | Intramucinous Adenocarcinoma

France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic

United States, Bulgaria
BioMarin Pharmaceutical

Completed

Kuvan® in Phenylketonuria Patients Less Than 4 Years Old (SPARK)

Phenylketonuria

Italy, Turkey, United Kingdom, Germany, Netherlands, Slovakia, Austria, Belgium, Czechia
Cosmo Technologies Ltd

Completed

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

Adenomas

United Kingdom, United States, Italy
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) (ESPART)

Infertility

Germany

3

Subscribe